Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02668705 · ClinicalTrials.gov registry record · NA
Agent-Enhanced Document Explanation
A NA study, sponsored by Boston Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT02668705 is a NA study that was terminated before completion, run by Boston Medical Center. The registered enrollment target is 101 participants.
The verdict
NCT02668705, a NA study, was terminated before completion, sponsored by Boston Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
Both the main and sub-studies will investigate how consent forms and other health care documents are explained to patients. The findings will be used to create a computer program that can successfully explain consent and other health-related forms to individuals who have difficulty reading and understanding consent forms on their own as a supplement to the normal consent process done in research settings.
Interventions
- OTHER Embodied Conversational Agent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02668705
The ClinicalTrials.gov registry entry for NCT02668705 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Embodied Conversational Agent is the first listed.
NCT02668705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02668705 about?
NCT02668705 is a clinical study titled "Agent-Enhanced Document Explanation". Both the main and sub-studies will investigate how consent forms and other health care documents are explained to patients. The findings will be used to create a computer program that can successfully explain consent and other health-related forms to individuals who have difficulty reading and under...
What is the current status of trial NCT02668705?
This trial is currently terminated. It is a NA study. The enrollment target is 101 participants. The study started on 2015-09. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02668705?
The interventions under investigation include: Embodied Conversational Agent (OTHER).
Who is sponsoring clinical trial NCT02668705?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.